Alan Potts
Director of Analytical Development at ContraFect Corp | Analytical Development, CMC Lead, Product Quality
- Role
- Director of Analytical Development at Contrafect Corp
- Location
- Raleigh, NC, US
- LinkedIn followers
- 500 followers
About Alan Potts
With over twenty years of experience in analytical development, I lead the CMC analytical development of novel direct lytic agents for the treatment of infections at ContraFect Corp. My mission is to apply my expertise in bioassays, spectroscopy, chromatography, and pharmaceutical product development to create innovative and effective solutions for patients in need. I have a proven track record of managing complex projects, such as clinical formulation development, CMC NDA compilation and FDA PAI audit, and manufacturing process validation. I also have extensive experience in leading and mentoring teams of scientists responsible for developing and validating analytical methods for drug substance and drug product applications. I am passionate about quality and compliance, and I have implemented and improved corrective and preventive action (CAPA) systems and quality control processes in my previous and current roles. I am always eager to learn new analytical technologies and techniques, and to apply them to development, manufacturing, and problem solving.
Experience
Director of Analytical Development
Feb 2023 — Present · Raleigh, NC, US
Responsible for the CMC analytical development of novel direct lytic agents for the treatment of infections.
Education
Syracuse University
BS, Chemistry
1988 — 1992
The University of North Carolina at Chapel Hill
Ph.D., Physical Chemistry
1992 — 1997
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.